Member Info for mulledwine

Dr Nick Ash, CEO of Source BioScience, added: "The breadth and depth of this research resource has been significantly enhanced as a result of Source BioScience acquiring Berlin-based imaGenes in 2010. In the six months since the acquisition we have fully integrated the business activities and have combined both companies' clone and antibody portfolios. Over £1 million has been invested in GenomeCube® to create a single, intelligent portal to enable ready access to the entire portfolio. The launch of this service marks a significant milestone for the Company."

Over 20 million DNA clones and 90,000 antibodies publicly available via powerful, new GenomeCube® search engine Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, announces the launch of the largest publicly available clone and antibody resource portfolio for research purposes in the world in conjunction with an innovative, intelligent search engine to provide ready access for researchers. Researchers will be able to access over 20 million clones, representing nearly every known human gene and most other organisms important in biological research. In addition, there is a portfolio of over 90,000 antibodies for applications in both research and diagnostics. Clones and antibodies are used as primary research tools across a broad spectrum of biological sciences. Currently, Source BioScience supplies research resources, screening and diagnostic services to the life sciences industry in over 90 countries worldwide. Super fast access and intuitive searching of the vast portfolio will be possible with the new Source BioScience GenomeCube® search engine. GenomeCube® is an intelligent web-based portal which can search the entire Source BioScience clone and antibody portfolio using an array of search terms and common identifiers used in international scientific databases. Dr Nick Leaves, COO at Source BioScience, commented: "The Source BioScience clone and antibody resource represents an invaluable tool for biological research. Researchers will now be able to locate and buy these products from a single site. In addition, with the launch of our enhanced search engine, GenomeCube®, researchers will be able to access this library with comprehensive annotation, and scientific and technical support in a fraction of the time. We believe this one-stop shop will make a significant difference to researchers." As an indication of the utility and power of the new search engine, more than 10 million links have been established from international scientific databases to GenomeCube® to enable scientists access to the most current and detailed information to support their research.

http://www.investegate.co.uk/Article.aspx?id=201106220700128585I

Good news for MOG - hopefully may see some recent losses recouped

Michael Bonte-Friedheim, the Company's CEO, stated: "We are very pleased to have concluded the gas sales contract with Elettrogas. The contract's flexibility allows us to manage possible variations to the development plan that might emerge, substantially mitigating our volume and price risk. The Guendalina development is progressing well and on schedule. The development represents one of the key milestones of the Company's business plan that will allow it to significantly increase net gas production and revenues once this comes on stream in late September."

Italy - Guendalina Gas Field (MOG interest 20%; ENI 80% and Operator) Announcement of Gas Sale Contract The Board of Mediterranean Oil & Gas Plc (AIM: MOG), the central Mediterranean focused producer, developer and explorer of oil and gas assets, is pleased to announce that its subsidiary Medoilgas Italia SpA has signed a gas sales contract with the Italian utility Elettrogas SpA covering the entirety of the Company's net gas production from the Guendalina gas field. The term of the contract is one thermal year, commencing from October 1, 2011 and is automatically renewed by a further year unless terminated by either party. First production from the Company's Guendalina gas field is expected in late September 2011. Based on the contract's gas price formula, the current and forecast average gas price is €0.306/cubic meter (US$11.50 /thousand cubic feet). Management expect net revenues to MOG to be approximately €12 million per annum, based on anticipated production of approximately 20 MMcf/day (20% net to MOG) and forecast gas prices.

http://www.investegate.co.uk/Article.aspx?id=201106220700098433I

GALLIFORD TRY REACHES FINANCIAL CLOSE ON £50 MILLION HALTON BSF Galliford Try plc, the housebuilding and construction group, announces that the Halton Transformational Partnership (a consortium of Galliford Try, Hochtief PPP Solutions and VINCI Construction UK) has reached financial close as the construction and investment partner undertaking the £50 million Halton Building Schools for the Future programme. Following financial close, Galliford Try will carry out the redevelopment of The Grange School in Runcorn and the redevelopment of Wade Deacon High School in Widnes, in joint venture with VINCI. Work will commence in June 2011 and completion of construction is expected in April 2013. Galliford Try Chief Executive, Greg Fitzgerald commented: "We are delighted to reach financial close as a construction and investment partner on this significant project which reinforces our strong reputation and market position in the education sector."

http://www.halifaxmarketwatch.co.uk/rns.cgi?username=&ac=&action=news&rns=1&view=full&story_id=4308941

Commenting on the announcement, Roel Pieper, CEO of PDX said: "The signing of our agreement with Advanced BioEnergy, alongside the recent agreements with BioFuel Energy, Marquis Energy and Front Range Energy LLC, demonstrates clearly the increasing industry acceptance and growing momentum of the PDX technology in the corn ethanol industry. With each plant that we sign-up, we continue to improve the period from installation to revenues per plant, as we streamline the process and produce more effective efficiency calculations to determine the shared benefits. We are on track to meet our biofuels installed capacity guidance for the full year".

Three new biofuels plants signed PDX (AIM:PDX) is pleased to announce today the signing of an agreement with Advanced BioEnergy, LLC ("ABE") to install the Ethanol Reactor System ("ERS") at its three plants in South Dakota and Nebraska, totalling 195 million US Gallons per annum ("Gpa"). This agreement enables PDX to install the ERS and determine its performance in these plants. Subject to this satisfactory operational validation, the next stage of the process will be the agreement of commercial terms and the commencement of revenues. Today's agreement follows two other significant biofuels agreements announced at the interim results on 14 June 2011: · Marquis Energy LLC ("Marquis"), one of the largest ethanol plants in the USA with a production rate of 135 million Gpa, agreed commercial terms with PDX over its operation of the ERS at its plant at Hennepin, IL, USA. The Marquis plant ERS was installed in March this year. · BioFuel Energy, LLC ("BFE") signed an agreement to install the ERS at two of its plants in Nebraska and Minnesota. Each plant has a capacity of 115 million Gpa. Altogether, the signing of today's agreement will bring the total number of plants installed or contracted to be installed to 13, with a total capacity of 914 million Gpa. PDX reiterates the guidance given in its interim results statement on 14 June 2011 that by the end of the current financial year it expects to have an installed base of more than 500 million Gpa and over two billion Gpa by the end of financial year 2012. The recent agreements with ABE and BFE, alongside that with Front Range Energy LLC announced on 25 May 2011, are part of the second group of plants with which installation agreements have been signed. Group two plants are expected to generate slightly higher revenues than group one plants, equating to a 30% share of the benefits. PDX maintains its guidance of US$ 2c to 4c per gallon as the overall average share of the benefits. PDX expects that it will typically take approximately two to three months after an ERS is installed until it moves to the next stage where commercial terms are agreed and the plant starts to generate revenues. Taking this into account, PDX expects the actual annual run-rate revenues from its Biofuels Line of Business to be substantial and, when combined with its modest expense base, a major contributor to PDX's overall profitability. PDX therefore remains committed to its outlook of becoming cash flow positive in the first half of financial year 2012. See the table in the notes to editors for a detailed breakdown of all the plants with which PDX has signed agreements.

http://www.halifaxmarketwatch.co.uk/rns.cgi?username=&ac=&action=news&rns=1&view=full&story_id=4308986

Orosur Mining Orosur Mining Inc. Completes Private Placement Orosur Mining Inc. Completes Private Placement Orosur Mining Inc. Orosur Mining Inc. ("OMI" or the "Company") (TSX VENTURE: OMI) (LSE: OMI), the South American-focused gold producer and explorer, is pleased to announce that it has completed the previously announced private placement (the “Offering”) of Common shares of the Company (the “Common Shares”) at a price of 66 pence per Common Share for gross proceeds of £8,250,726.

http://www.investegate.co.uk/Article.aspx?id=20110622070000Z8529

Playtech Group (PTEC), the gaming software developer, has signed a software licensing agreement with the California Online Poker Association (COPA) for the provision of online poker software. California is currently considering legislation that would allow legal operation of intrastate, Internet poker and in advance COPA will offer the game in a "play for fun" mode. Broker Evolution Securities said on the news, "This announcement supports our bull stance....we reiterate our Buy stance and ...550p target price. Playtech shares moved up by 15.25p to 335p.

Defence business Cobham (COB) saw its shares rise by 2.7p to 207.4p as it announced a five year professional services contract with the Deputy Assistant Secretary of Defense (DASD), Developmental Test and Evaluation (DDT&E). The firm will act as prime supplier under the $190 million deal. Cobham has also won a $6.3 million, five year contract to provide professional services to the Deputy for Capability Development.

Roaring trade at its Costa Coffee business helped hotel & restaurant group Whitbread (WTB) to grow total group sales by 9.2% in the 13 weeks to 2nd June 2011. Following the opening of an additional 73 Costa outlets in the quarter sales at the cafe chain were up by an impressive 22.5%. Elsewhere in the group, sales at Premier Inn were up by 8.1% and sales at the Hotels & Restaurants business were up by 4.8%. Total like-for-like sales across the group in the period were up by 1.7%. The shares were the best performing of the day in the FTSE 100, rising by 102p to 1,587p.

21st June 2011 Analyst: Derren Nathan Email: derren.nathan@gecr.co.uk Tel: 0207 562 3371 Intandem Films * - Expansion of film slate - Introduction of 2013 forecasts - Upgrade from HOLD to BUY at 5.5p with a revised target price of 12p from 7p.

Halfords, the car parts and bicycle retailer, is a stock firmly out of favour with the market, reflecting the challenging macro-economic backdrop and more cautious consumer sentiment. On valuation grounds the shares look compelling, with the added attraction of a yield in excess of 5.5 per cent. The board’s decision to recommend a 10 per cent increase in Halford’s full-year dividend reaffirms its progressive dividend policy and confidence going forwards. Buy, recommends the Scotsman.

One of those engineering shares dragged lower by the Charter International profits warning was Bodycote, which ended 14p lower at 338p, says the Times. The share price fall did take the shine off some good news the company was keen to announce from the Paris Air Show. Rolls-Royce, which is one of the company’s five biggest customers, has signed another ten-year agreement to continue to use Bodycote for the work to service and heat-treat its aero engine blades. The shares are on about 12 times’ this year’s earnings, which is relatively low for the stock, and could have further to go, absent any real economic meltdown, the paper writes.